Abstract
Sequence-specific targeting of double-stranded DNA (dsDNA) using synthetic oligonucleotides (ONs) has been under investigation in different therapeutic approaches. Several methods can be used to evaluate ONs effect and binding capacity to their target sequence. Here we describe some of the methods, which have been frequently used for assessing ONs binding to dsDNA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Smith CIE, Zain R (2019) Therapeutic oligonucleotides: state of the art. Annu Rev Pharmacol Toxicol 59:605–630. https://doi.org/10.1146/annurev-pharmtox-010818-021050
Lundin KE, Gissberg O, Smith CI (2015) Oligonucleotide therapies: the past and the present. Hum Gene Ther 26(8):475–485. https://doi.org/10.1089/hum.2015.070. Epub 2015 Aug 1083
Crooke ST (2004) Antisense strategies. Curr Mol Med 4(5):465–487
Davidson BL, McCray PB Jr (2011) Current prospects for RNA interference-based therapies. Nat Rev Genet 12(5):329–340. https://doi.org/10.1038/nrg2968
Goodchild J (2011) Therapeutic oligonucleotides. Methods Mol Biol 764:1–15. https://doi.org/10.1007/1978-1001-61779-61188-61778_61771
Kole R, Krainer AR, Altman S (2012) RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 11(2):125–140. https://doi.org/10.1038/nrd3625
Moser HE, Dervan PB (1987) Sequence-specific cleavage of double helical DNA by triple helix formation. Science 238(4827):645–650
Pauling L, Corey RB (1953) A proposed structure for the nucleic acids. Proc Natl Acad Sci U S A 39(2):84–97
Bacolla A, Wells RD (2009) Non-B DNA conformations as determinants of mutagenesis and human disease. Mol Carcinog 48(4):273–285. https://doi.org/10.1002/mc.20507
Bergquist H, Rocha CS, Alvarez-Asencio R, Nguyen CH, Rutland MW, Smith CI, Good L, Nielsen PE, Zain R (2016) Disruption of higher order DNA structures in Friedreich’s ataxia (GAA)n repeats by PNA or LNA targeting. PLoS One 11(11):e0165788. https://doi.org/10.1371/journal.pone.0165788
Loenen WA, Dryden DT, Raleigh EA, Wilson GG, Murray NE (2014) Highlights of the DNA cutters: a short history of the restriction enzymes. Nucleic Acids Res 42(1):3–19. https://doi.org/10.1093/nar/gkt990
Pingoud A, Jeltsch A (2001) Structure and function of type II restriction endonucleases. Nucleic Acids Res 29(18):3705–3727
Nielsen PE, Egholm M, Berg RH, Buchardt O (1993) Sequence specific inhibition of DNA restriction enzyme cleavage by PNA. Nucleic Acids Res 21(2):197–200
Zaghloul EM, Gissberg O, Moreno PMD, Siggens L, Hallbrink M, Jorgensen AS, Ekwall K, Zain R, Wengel J, Lundin KE, Smith CIE (2017) CTG repeat-targeting oligonucleotides for down-regulating Huntingtin expression. Nucleic Acids Res 45(9):5153–5169. https://doi.org/10.1093/nar/gkx111
Vogt VM (1973) Purification and further properties of single-strand-specific nuclease from Aspergillus oryzae. Eur J Biochem 33(1):192–200
Evans T, Efstratiadis A (1986) Sequence-dependent S1 nuclease hypersensitivity of a heteronomous DNA duplex. J Biol Chem 261(31):14771–14780
Balagurumoorthy P, Adelstein SJ, Kassis AI (2008) Method to eliminate linear DNA from mixture containing nicked circular, supercoiled, and linear plasmid DNA. Anal Biochem 381(1):172–174. https://doi.org/10.1016/j.ab.2008.06.037
Pabon-Martinez YV, Xu Y, Villa A, Lundin KE, Geny S, Nguyen CH, Pedersen EB, Jorgensen PT, Wengel J, Nilsson L, Smith CIE, Zain R (2017) LNA effects on DNA binding and conformation: from single strand to duplex and triplex structures. Sci Rep 7(1):11043. https://doi.org/10.1038/s41598-017-09147-8
Hartono YD, Pabon-Martinez YV, Uyar A, Wengel J, Lundin KE, Zain R, Smith CIE, Nilsson L, Villa A (2017) Role of pseudoisocytidine tautomerization in triplex-forming oligonucleotides: in silico and in vitro studies. ACS Omega 2(5):2165–2177. https://doi.org/10.1021/acsomega.7b00347
Helene C (1991) The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides. Anticancer Drug Des 6(6):569–584
Knauert MP, Glazer PM (2001) Triplex forming oligonucleotides: sequence-specific tools for gene targeting. Hum Mol Genet 10(20):2243–2251
Duca M, Vekhoff P, Oussedik K, Halby L, Arimondo PB (2008) The triple helix: 50 years later, the outcome. Nucleic Acids Res 36(16):5123–5138. https://doi.org/10.1093/nar/gkn493
Zaid A, Sun JS, Nguyen CH, Bisagni E, Garestier T, Grierson DS, Zain R (2004) Triple-helix directed cleavage of double-stranded DNA by benzoquinoquinoxaline-1,10-phenanthroline conjugates. Chembiochem 5(11):1550–1557. https://doi.org/10.1002/cbic.200400074
Escude C, Nguyen CH, Kukreti S, Janin Y, Sun JS, Bisagni E, Garestier T, Helene C (1998) Rational design of a triple helix-specific intercalating ligand. Proc Natl Acad Sci U S A 95(7):3591–3596
Zain R, Marchand C, Sun J, Nguyen CH, Bisagni E, Garestier T, Helene C (1999) Design of a triple-helix-specific cleaving reagent. Chem Biol 6(11):771–777
Bentin T, Larsen HJ, Nielsen PE (2003) Combined triplex/duplex invasion of double-stranded DNA by “tail-clamp” peptide nucleic acid. Biochemistry 42(47):13987–13995. https://doi.org/10.1021/bi0351918
Moreno PM, Geny S, Pabon YV, Bergquist H, Zaghloul EM, Rocha CS, Oprea II, Bestas B, Andaloussi SE, Jorgensen PT, Pedersen EB, Lundin KE, Zain R, Wengel J, Smith CI (2013) Development of bis-locked nucleic acid (bisLNA) oligonucleotides for efficient invasion of supercoiled duplex DNA. Nucleic Acids Res 41(5):3257–3273. https://doi.org/10.1093/nar/gkt007
Kuśmierek JT, Singer B (1982) Chloroacetaldehyde-treated ribo- and deoxyribopolynucleotides. 1. Reaction products. Biochemistry 21(22):5717. https://doi.org/10.1021/bi00265a050
Zianni M, Tessanne K, Merighi M, Laguna R, Tabita FR (2006) Identification of the DNA bases of a DNase I footprint by the use of dye primer sequencing on an automated capillary DNA analysis instrument. J Biomol Tech 17(2):103
Acknowledgments
This work was supported by the European Union’s Horizon 2020 under the Marie Skłodowska-Curie grant agreement No 721613, the Swedish Research Council, the Stockholm County Council, Hjärnfonden, and Vinnova/SweLife.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Mozafari, N., Umek, T. (2019). Assessing Oligonucleotide Binding to Double-Stranded DNA. In: Gissberg, O., Zain, R., Lundin, K. (eds) Oligonucleotide-Based Therapies. Methods in Molecular Biology, vol 2036. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9670-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9670-4_5
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9669-8
Online ISBN: 978-1-4939-9670-4
eBook Packages: Springer Protocols